Revolve Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Buy
1,757
+179
+11% +$183K 0.22% 67
2026
Q1
$1.45M Sell
1,578
-18
-1% -$18.2K 0.19% 71
2025
Q4
$1.72M Buy
1,596
+158
+11% +$151K 0.2% 66
2025
Q3
$1.1M Sell
1,438
-92
-6% -$68.5K 0.13% 84
2025
Q2
$1.19M Sell
1,530
-84
-5% -$65.3K 0.16% 73
2025
Q1
$1.33M Buy
1,614
+143
+10% +$119K 0.19% 66
2024
Q4
$1.14M Buy
1,471
+40
+3% +$33.1K 0.17% 71
2024
Q3
$1.27M Buy
1,431
+30
+2% +$27K 0.19% 62
2024
Q2
$1.27M Buy
1,401
+9
+0.6% +$7.2K 0.21% 58
2024
Q1
$1.08M Buy
1,392
+96
+7% +$68.3K 0.19% 63
2023
Q4
$755K Buy
1,296
+44
+4% +$25.7K 0.15% 69
2023
Q3
$672K Buy
1,252
+93
+8% +$47.9K 0.16% 71
2023
Q2
$544K Buy
1,159
+147
+15% +$61.6K 0.13% 78
2023
Q1
$348K Sell
1,012
-13
-1% -$4.38K 0.09% 102
2022
Q4
$375K Buy
1,025
+151
+17% +$53.5K 0.11% 92
2022
Q3
$283K Buy
874
+64
+8% +$20.3K 0.09% 96
2022
Q2
$263K Buy
810
+100
+14% +$30K 0.09% 103
2022
Q1
$203K Buy
+710
New +$183K 0.06% 143

Other funds holding LLY